News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Magnetics, Inc. (AMAG) to Present at the Bank of America (BAC) Health Care Conference


5/24/2007 1:53:49 PM

CAMBRIDGE, Mass., May 24 /PRNewswire-FirstCall/ -- Advanced Magnetics, Inc. today announced that it will participate in the Bank of America Health Care Conference being held May 30-June 1, 2007 at the Four Seasons Hotel in Las Vegas, NV. Brian J.G. Pereira, MD, President and CEO of Advanced Magnetics, will present an overview of the company on Wednesday, May 30, at 3:20 pm PDT.

A live webcast of this presentation will be accessible through the Investors section of the company's website at www.advancedmagnetics.com. Following the conference, the webcast will be archived on the Advanced Magnetics website until June 15, 2007.

About Advanced Magnetics

Advanced Magnetics, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. The company has completed enrollment in four Phase III clinical trials with ferumoxytol and has presented data on three of the four trials.

Combidex, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging (MRI) to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.

The company has two commercial products, Feridex I.V.(R) and GastroMARK(R), both of which are imaging agents that are approved and marketed in the United States, Europe and other countries.

Contact: Kristen Galfetti Senior Director, Investor Relations kgalfetti@advancedmagnetics.com (617) 498-3362

Advanced Magnetics, Inc.

CONTACT: Kristen Galfetti, Senior Director, Investor Relations,+1-617-498-3362, kgalfetti@advancedmagnetics.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES